Innovator’s Pitch Challenge

Interested in Connecting? Please contact:

SaeGwang Park

Message the company or request a 1:1 meeting here

Company Description

NexThera Co., Ltd. is a biotech venture company leveraging its recombinant protein-based platform technology — including peptides — to develop a novel therapeutic and delivery platform for wet age-related macular degeneration (wAMD), biobetter development, and antibody-based therapeutic for thrombocytopenia. By collaborating and forging partnerships with leading universities, research institutions, hospitals, and other key opinion leaders in the industry, NexThera is dedicated to developing novel therapies, biobetters, and platforms that contribute to human health. NexThera strives to grow as a socially responsible biotech company by contributing to a thriving local bio-ecosystem, supporting job creation, and creating an environment where young and talented scientists can fully devote themselves to cutting-edge research.


Pitch Deck

Pitch Video